News

The Manila Times59m
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the ...
pharmaphorum7m
New medicine access times to be slashed under NHS plan
A new task force comprising staff from the UK medicines regulator, the MHRA, and cost-effectiveness arbiter NICE – with the ...